Related references
Note: Only part of the references are listed.Cancer statistics, 2013
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
The State of Molecular Biomarkers for the Early Detection of Lung Cancer
Mohamed Hassanein et al.
CANCER PREVENTION RESEARCH (2012)
Anaphylatoxin C5a Creates a Favorable Microenvironment for Lung Cancer Progression
Leticia Corrales et al.
JOURNAL OF IMMUNOLOGY (2012)
Pros and cons for C4d as a biomarker
Danielle Cohen et al.
KIDNEY INTERNATIONAL (2012)
Genetic and Pharmacologic Inhibition of Complement Impairs Endothelial Cell Function and Ablates Ovarian Cancer Neovascularization
Selene Nunez-Cruz et al.
NEOPLASIA (2012)
Immunotherapy for Non-small Cell Lung Cancer Novel Approaches to Improve Patient Outcome
Frances A. Shepherd et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Combined VEGF-A and VEGFR-2 concentrations in plasma: Diagnostic and prognostic implications in patients with advanced NSCLC
Eloisa Jantus-Lewintre et al.
LUNG CANCER (2011)
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
Denise R. Aberle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer
Mattia Boeri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Complement Factor H Is Elevated in Bronchoalveolar Lavage Fluid and Sputum from Patients with Lung Cancer
Ruben Pio et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Cancer and the Complement Cascade
Martin J. Rutkowski et al.
MOLECULAR CANCER RESEARCH (2010)
New insights into the molecular mechanisms of classical complement activation
Mihaela Kojouharova et al.
MOLECULAR IMMUNOLOGY (2010)
Complement: a key system for immune surveillance and homeostasis
Daniel Ricklin et al.
NATURE IMMUNOLOGY (2010)
Hypoxia increases susceptibility of non-small cell lung cancer cells to complement attack
Marcin Okroj et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
C1q binds phosphatidylserine and likely acts as a multiligand-bridging molecule in apoptotic cell recognition
Helena Paidassi et al.
JOURNAL OF IMMUNOLOGY (2008)
Non-small cell lung cancer cells produce a functional set of complement factor I and its soluble cofactors
Marcin Okroj et al.
MOLECULAR IMMUNOLOGY (2008)
Modulation of the antitumor immune response by complement
Maciej M. Markiewski et al.
NATURE IMMUNOLOGY (2008)
Down-regulation of human complement factor h sensitizes non-small cell lung cancer cells to complement attack and reduces in vivo tumor growth
Daniel Ajona et al.
JOURNAL OF IMMUNOLOGY (2007)
Multiple oncogenic changes (K-RASV12, p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells
M Sato et al.
CANCER RESEARCH (2006)
Differential exoprotease activities confer tumor-specific serum peptidome patterns
J Villanueva et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Expression of complement factor H by lung cancer cells:: Effects on the activation of the alternative pathway of complement
D Ajona et al.
CANCER RESEARCH (2004)
Specific inhibition of the classical complement pathway by C1q-binding peptides
A Roos et al.
JOURNAL OF IMMUNOLOGY (2001)
Share Paper
